| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | $0.00 | – | – | $33.19M | $18.82M |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | $384.64M | $252.05M | $171.29M | $167.56M | $148.74M |
| R&D | $208.44M | $184.55M | $121.90M | $124.44M | $108.47M |
| SG&A | $176.21M | $67.50M | $49.40M | $43.12M | $40.27M |
| Operating Income | -$384.64M | -$252.05M | -$171.29M | -$134.37M | -$129.92M |
| Interest Expense | $6.30M | $6.60M | $6.50M | $4.70M | $2.10M |
| Tax Expense | – | – | – | – | – |
| Net Income | -$377.94M | -$246.29M | -$165.79M | -$134.50M | -$131.80M |
| EPS (basic) | -3.2900 | -2.4700 | -1.9900 | -2.2600 | -3.5900 |
| EPS (diluted) | -3.2900 | -2.4700 | -1.9900 | -2.2600 | -3.5900 |
| Shares (diluted) | $114.70M | $99.84M | $83.35M | $59.61M | $36.71M |